Parkside Financial Bank & Trust Acadia Pharmaceuticals Inc Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 90 shares of ACAD stock, worth $1,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90Holding current value
$1,997% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$951 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$337 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$268 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$190 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$155 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.59B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...